ストックスクリーナーアプリを入手
201.11
0.54%
1.0801
アフターアワーズ：
201.06
-0.0497
-0.02%
前日終値:
$200.03
開ける：
$200.1
24時間の取引高:
14,301
Relative Volume:
1.73
時価総額：
$N/A
収益：
-
当期純損益:
-
株価収益率:
-
EPS:
-
ネットキャッシュフロー:
-
1週間 パフォーマンス:
+5.24%
1か月 パフォーマンス:
+4.51%
6か月 パフォーマンス:
+21.90%
1年 パフォーマンス:
+22.20%
1日の値動き範囲:
$200.10
$202.91
1週間の範囲:
$193.37
$202.91
52週間の値動き範囲:
$135.34
$202.91
Vaneck Biotech Etf Stock (BBH) Company Profile
BBH を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
BBH
Vaneck Biotech Etf
|
201.11 | 0 | 0 | 0 | 0 | 0.00 |
|
VTI
Vanguard Total Stock Market Etf
|
343.27 | 417.53B | 0 | 0 | 0 | 0.00 |
|
SPY
Spdr S P 500 Etf Trust
|
695.49 | 372.57B | 0 | 0 | 0 | 0.00 |
|
IVV
Ishares Core S P 500 Etf
|
698.65 | 253.41B | 0 | 0 | 0 | 0.00 |
|
VB
Vanguard Small Cap Etf
|
274.07 | 160.59B | 0 | 0 | 0 | 0.00 |
|
QQQ
Invesco Qqq Trust Series 1
|
631.13 | 124.43B | 0 | 0 | 0 | 0.00 |
Vaneck Biotech Etf (BBH) 最新ニュース
Best Biotech ETFs to Watch Right Now - The Motley Fool
Moderna’s rally ripples through biotech and health care ETFs - MSN
BBH: Mature Biotech Exposure, But Limited Growth Ahead (NASDAQ:BBH) - Seeking Alpha
Precious Metals Define Commodity Performance in 2025 - VanEck
IYH: Elevated Valuations And Slowing Growth Signal Subpar 2026 Returns - Seeking Alpha
Why VanEck Morningstar International Moat ETF stock is upgraded to buyJuly 2025 Macro Moves & Free Community Consensus Stock Picks - ulpravda.ru
Should You Invest in the VanEck Biotech ETF (BBH)? - Yahoo Finance
As Gold Soars, Opportunity Lies in ‘Better, Not Bigger’ Mining Acquisitions - VanEck
Short Interest in VanEck Biotech ETF (NASDAQ:BBH) Decreases By 16.5% - Defense World
How to Buy Gilead Sciences Stock (GILD) - The Motley Fool
Biogen: Competing With Eli Lilly's Kisunla, Safety Gives Market Edge (NASDAQ:BIIB) - Seeking Alpha
VanEck Biotech ETF declares annual distribution of $0.9565 - MSN
3 ASX ETFs to target in the new year – the booming themes of 2025 - The Motley Fool Australia
Day by day downgrades VanEck ETF TrustVanEck Biotech ETF (BBH) - MSN
Can Amgen Sustain Its Rally In 2026 (NASDAQ:AMGN) - Seeking Alpha
Why Are Investors Re-Evaluating Large Pharmaceutical Companies? - VanEck
Novo Nordisk's Wegovy Pill Shakes Up Rivalry With Eli Lilly, Puts Health Care ETFs In Focus - Sahm
VanEck Mid-December 2025 Bitcoin ChainCheck - VanEck
VanEck Announces Year-End Distributions for VanEck Equity ETFs - Crypto Reporter
VanEck ETF TrustVanEck Biotech ETF announces Annual dividend, payable on December 26, 2025 - marketscreener.com
Defense Start-ups Galvanize a Once Sleepy Sector - VanEck
5 Best ETFs for Tax-Loss Harvesting | Investing | U.S. News - US News Money
What If AI Went Away Today? A Simple Look at Semiconductors - VanEck
November Market Recap: AI Adoption Surges & Tight Liquidity Creates Opportunity - VanEck
The Fed cut interest rates and bought short-term bonds, Powell leaned dovish, US stocks, short-term US bonds, and gold rose, the dollar fell, while Bitcoin fluctuated. - 富途牛牛
Biotech may still have life - Investment Executive
EDGAR Filing Documents for 0000930413-25-003577 - SEC.gov
How Much More Tightening in EM? - VanEck
Inflation Persistence in EM - VanEck
Chinese Bonds Offer Yield Pickup - VanEck
AI Revolutionizes Pharma and Biotech Sectors: Market Trends for 2025 - Blockchain News
EM High Yield Corporates: Superior Yields, Low Defaults - VanEck
How India’s Digital Economy Compares to China - VanEck
InflationDownside Surprises Stage Comeback - VanEck
Higher for LongerMarket Not So Sure - VanEck
Global Pressures – Pick a Direction - VanEck
AI in Pharma and Biotech: Market Trends 2025 and Beyond - VanEck
AI In Pharma And Biotech: Market Trends 2025 And Beyond - Seeking Alpha
China – Lockdowns, Growth, Policy Options - VanEck
Sentiment Swings and Fundamentals - VanEck
Tema’s Oncology ETF (CANC) Surpasses $100m in Assets Amidst Strong 2025 Performance - The AI Journal
The Global Power Crunch: The New Geopolitical and Economic Frontier - VanEck
Rates and Consequences - VanEck
Gold Responds and Reminds in March - VanEck
Pharma ETFs: Your Key to Diversification in the Pharmaceutical Sector - Investing News Network
Uncover Big Opportunities in Smaller Companies - VanEck
The Future of Fandom: Why Esports and Gaming Are Outpacing Traditional Sports - VanEck
Investing in Semiconductor ETFs & Stocks - VanEck
SMH ETF: Question & Answer - VanEck
If You’re Reading This Semiconductors & AI Are Taking Over - VanEck
2025 Semiconductor Outlook: Investor Roadmap - VanEck
Vaneck Biotech Etf (BBH) 財務データ
Vaneck Biotech Etf (BBH) の財務データはありません。詳細については、他の銘柄を確認してください。
収益
当期純利益
現金流量
EPS
0.03%
0.64%
大文字化:
|
ボリューム (24 時間):